Risk factors for thiopurine-related toxicity in Latin American inflammatory bowel disease patients.
文献摘要
Objectives Thiopurines continue to play a role in inflammatory bowel disease (IBD) treatment, particularly in resource-limited countries. However, there are scarce data from Latin America regarding thiopurines-associated AE. We aim to describe the thiopurine-associated AE and determine risk factors for its occurrence. Materials and methods Clinical data from IBD patients treated with thiopurines in a Chilean tertiary centre were retrospectively collected including AE that required thiopurine withdrawal and weight-based thiopurine dose. A multivariable model was fitted to determine independent risk factors of thiopurine-related AE. Odds ratios (OR) and 95% confidence intervals (CI) were calculated. Results A total 163 out of 587 (27.7%) patients discontinued thiopurine treatment due to AE including myelosuppression, hepatitis, pancreatitis, and gastrointestinal intolerance. Multivariate analysis showed that older age (OR: 1.02; 95% CI: 1.01-1.04; p=0.01) and lower body weight (OR: 0.97; 95% CI: 0.95-0.99; p=0.01) were independent risk factors for thiopurine-associated AE. Conclusions Discontinuation of thiopurines due to AE is frequent in Latin IBD patients. Particular caution should be exerted in older and low-weight IBD patients starting thiopurine treatment.